Medicines for Africa
  • Home
  • About Us
  • Products and Services
  • Health Security & Sovereignty
  • Contact us
  • Home
  • About Us
  • Products and Services
  • Health Security & Sovereignty
  • Contact us
Search by typing & pressing enter

YOUR CART

Picture
On Let's Talk about Health in Africa Lenias Hwenda takes an in-depth look at the state of public health in African countries through one-on-one conversations and roundtable discussions with leaders and change makers from various sectors of the economy that impacts the health of Africans. Leaders, change makers and ordinary people share their insights, analysis and perspectives to help you make sense of the issues affecting the governance of health in Africa, how they are being tackled, whether this is working and what is needed to close the gap between the status quo and meaningful transformation of the lives of Africans.
Subscribe
Let's Talk about Health in Africa Blog

10/1/2017

Diabetes in Africa

Picture

Lenias Hwenda

Geneva Switzerland: Lenias Hwenda is a global health policy expert with a passion for improving access to quality affordable treatments. 


​Diabetes and its complications are rising to epidemic levels in African countries.

​
The WHO estimates that the Africa region had an estimated 11.7 million adults suffering from diabetes in 2011. This number is anticipated to more than double by 2030 if action is not taken. Poor diagnosis and and poor availability of affordable treatments are major concerns.

The WHO predicts that many people in African countries, die from lack of insulin, or develop complication, before they have had a chance to be diagnosed, let alone receive treatment. The WHO estimates that in 2012, diabetes was the direct cause of 1.5 million deaths worldwide. In the same year, UNAIDS estimates that 1.6 million people died of HIV/AIDS related causes worldwide.

​Proven low cost interventions exist that are capable of reducing the impact of diabetes while simultaneously addressing risks of other diseases.
Challenges to effective management of diabetes in African countries include poor access to diagnosis, affordable quality medicines, technologies and equipment necessary for treatment and the poor availability of appropriately trained staff and weak health systems. In cases where people are diagnosed, few have sufficient access to insulin, syringes and monitoring equipment. Early mortality is common in children with type 1 diabetes, regardless of whether they have been appropriately diagnosed or not. Early mortality significantly contributes to the low prevalence of type 1 diabetes in African countries.

Comments are closed.

    Blog: Let us Talk about Health in Africa

    .

    Follow us on social media


    Archives

    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    November 2020
    October 2020
    April 2020
    January 2020
    July 2019
    July 2018
    June 2018
    December 2017
    August 2017
    May 2017
    April 2017
    February 2017
    January 2017

    Categories

    All

    RSS Feed


Medicines For Africa

A company incorporated in South Africa. Registration Number: 201927530507 

Contact Details 

​33 Ballyclare Drive Ballywoods Office Park, Cedarwood House, 2191 Bryanstone, Johannesburg, South Africa
​
Telephone: +27 11  083 94 51 Email: info@medicines4africa.com